Who founded Watchmaker Genomics?

Watchmaker Genomics was founded by John Foskett in 2018.

Who are Watchmaker Genomics's investors?

Watchmaker Genomics's investors include Decheng Capital, Eclipse Ventures.

How much funding has Watchmaker Genomics raised?

Watchmaker Genomics has disclosed $48.3M raised across 2 rounds.

Where is Watchmaker Genomics headquartered?

Watchmaker Genomics is headquartered in Boulder, US.

Watchmaker Genomics

Boulder, US · Founded 2018 · Delaware corporation · 277 employees on LinkedIn · 2 known investors

Watchmaker Genomics develops and manufactures purpose-designed enzymes, reagents, and workflows for molecular biology and genomics applications, including inherited disease, somatic oncology, transcriptomics, and epigenomics research. It operates as an OEM supplier serving genomics technology developers and high-throughput sequencing labs.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Watchmaker Genomics was founded in 2018 by John Foskett.

John FoskettFounder

Brian DeneauinChief Operating and Finance Officer

Stephen PiconeinChief Strategic Officer

Brian KudlowinChief Scientific Officer

Trey FoskettinChief Executive Officer

Kerri StellatoinChief Commercial Officer

Eric van der WaltinChief Innovation Officer and Managing Director, South Africa

Paul McEwanNamed on SEC filing

Christopher McGuinnessNamed on SEC filing

Investors · 2

Decheng CapitalMenlo Park

Eclipse VenturesreportedPalo Alto · $200K – $5M

Reported raises · per SEC filings

Form D private placements

$48.3M disclosed across 2 rounds · 2020–2022

▶$40MraisedJun 2022 · 2 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Stephen PiconeExecutive Officer, Director, Promoter
Brian KudlowExecutive Officer, Director, Promoter
Brian DeneauExecutive Officer
Paul McEwanDirector, Promoter
Victor TongDirector
John FoskettExecutive Officer, Director, Promoter

Offering amount: $40M
Amount sold: $40M
First sale: May 2022
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$8.3MraisedDec 2020 · 27 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Paul McEwanDirector, Promoter
Christopher McGuinnessDirector
John FoskettExecutive Officer, Director, Promoter
Brian DeneauExecutive Officer, Director
Stephen PiconeExecutive Officer, Director, Promoter
Brian KudlowExecutive Officer, Director, Promoter

Offering amount: $8.3M
Amount sold: $8.3M
First sale: Jul 2020
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Watchmaker Genomics Raises $40M in Series A Financing | GenomeWebgenomeweb.com · Jun 2022

Watchmaker Genomics Raises $40M Series A Financing to Accelerate Growth and Expand Clinical Sequencing Product Offeringsprnewswire.com · Jun 2022

$40M Series A Financing to Expand Clinical Sequencing Offeringswatchmakergenomics.com · Jun 2022

Frequently asked questions

What does Watchmaker Genomics do?: Watchmaker Genomics develops and manufactures purpose-designed enzymes, reagents, and workflows for molecular biology and genomics applications, including inherited disease, somatic oncology, transcriptomics, and epigenomics research. It operates as an OEM supplier serving genomics technology developers and high-throughput sequencing labs.
Who founded Watchmaker Genomics?: Watchmaker Genomics was founded by John Foskett in 2018.
Who are Watchmaker Genomics's investors?: Watchmaker Genomics's investors include Decheng Capital, Eclipse Ventures.
How much funding has Watchmaker Genomics raised?: Watchmaker Genomics has disclosed $48.3M raised across 2 rounds.
Where is Watchmaker Genomics headquartered?: Watchmaker Genomics is headquartered in Boulder, US.